BioMarin Pharmaceutical Inc. (BMRN) Financial Statements (2025 and earlier)
Company Profile
Business Address |
105 DIGITAL DRIVE NOVATO, CA 94949 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 1,224,351 | 1,046,580 | 1,073,810 | 1,125,845 | 1,170,958 | 1,152,091 | |||
Cash and cash equivalents | 972,150 | 746,996 | 755,127 | 785,414 | 694,381 | 580,074 | |||
Short-term investments | 252,201 | 299,584 | 318,683 | 340,431 | 476,577 | 572,017 | |||
Receivables | 691,232 | 637,163 | 633,704 | 572,498 | 610,222 | 597,913 | |||
Inventory, net of allowances, customer advances and progress billings | 1,183,621 | 1,137,982 | 1,107,183 | 1,032,159 | 975,546 | 918,921 | |||
Inventory | 1,183,621 | 1,137,982 | 1,107,183 | 1,032,159 | 975,546 | 918,921 | |||
Other current assets | 160,426 | 163,287 | 141,391 | 224,806 | 193,391 | 173,180 | |||
Total current assets: | 3,259,630 | 2,985,012 | 2,956,088 | 2,955,308 | 2,950,117 | 2,842,105 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 1,052,898 | 1,060,425 | 1,066,133 | 1,067,156 | 1,067,278 | 1,068,142 | |||
Long-term investments and receivables | 557,083 | 620,551 | 611,135 | 548,002 | 385,777 | 340,635 | |||
Long-term investments | 557,083 | 620,551 | 611,135 | 548,002 | 385,777 | 340,635 | |||
Intangible assets, net (including goodwill) | 461,732 | 475,852 | 490,900 | 498,675 | 506,542 | 522,188 | |||
Goodwill | 196,199 | 196,199 | 196,199 | 196,199 | 196,199 | 196,199 | |||
Intangible assets, net (excluding goodwill) | 265,533 | 279,653 | 294,701 | 302,476 | 310,343 | 325,989 | |||
Deferred income tax assets | 1,545,006 | 1,546,043 | 1,545,809 | 1,523,953 | 1,509,290 | 1,510,568 | |||
Other noncurrent assets | 190,772 | 184,790 | 171,538 | 165,069 | 144,168 | 150,057 | |||
Total noncurrent assets: | 3,807,491 | 3,887,661 | 3,885,515 | 3,802,855 | 3,613,055 | 3,591,590 | |||
TOTAL ASSETS: | 7,067,121 | 6,872,673 | 6,841,603 | 6,758,163 | 6,563,172 | 6,433,695 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 572,500 | 593,543 | 683,147 | 669,825 | 597,231 | 598,231 | |||
Accrued liabilities | 174,268 | 164,738 | 218,017 | 198,749 | 155,069 | 171,556 | |||
Other undisclosed accounts payable and accrued liabilities | 398,232 | 428,805 | 465,130 | 471,076 | 442,162 | 426,675 | |||
Debt | 494,837 | 494,357 | 493,877 | 493,398 | |||||
Total current liabilities: | 1,067,337 | 1,087,900 | 1,177,024 | 1,163,223 | 597,231 | 598,231 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 594,116 | 593,605 | 593,095 | 592,586 | 1,084,994 | 1,084,006 | |||
Long-term debt, excluding current maturities | 594,116 | 593,605 | 593,095 | 592,586 | 1,084,994 | 1,084,006 | |||
Liabilities, other than long-term debt | 119,369 | 117,352 | 119,935 | 105,457 | 98,120 | 92,415 | |||
Other liabilities | 119,369 | 117,352 | 119,935 | 105,457 | 98,120 | 92,415 | |||
Total noncurrent liabilities: | 713,485 | 710,957 | 713,030 | 698,043 | 1,183,114 | 1,176,421 | |||
Total liabilities: | 1,780,822 | 1,798,857 | 1,890,054 | 1,861,266 | 1,780,345 | 1,774,652 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 5,286,299 | 5,073,816 | 4,951,549 | 4,896,897 | 4,782,827 | 4,659,043 | |||
Common stock | 190 | 190 | 189 | 188 | 188 | 188 | |||
Additional paid in capital | 5,696,701 | 5,619,264 | 5,611,562 | 5,542,774 | 5,493,956 | 5,417,873 | |||
Accumulated other comprehensive income (loss) | 26,799 | (1,046) | (28,788) | 6,257 | (18,617) | (10,722) | |||
Accumulated deficit | (425,718) | (532,892) | (621,554) | (641,929) | (682,307) | (738,347) | |||
Other undisclosed equity, attributable to parent | (11,673) | (11,700) | (9,860) | (10,393) | (10,393) | (9,949) | |||
Total equity: | 5,286,299 | 5,073,816 | 4,951,549 | 4,896,897 | 4,782,827 | 4,659,043 | |||
TOTAL LIABILITIES AND EQUITY: | 7,067,121 | 6,872,673 | 6,841,603 | 6,758,163 | 6,563,172 | 6,433,695 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 712,029 | 648,833 | 646,207 | 581,329 | 595,275 | 596,415 | ||
Cost of revenue | (130,459) | (125,180) | (135,478) | (124,745) | (128,082) | (126,549) | ||
Gross profit: | 581,570 | 523,653 | 510,729 | 456,584 | 467,193 | 469,866 | ||
Operating expenses | (461,118) | (435,191) | (481,274) | (415,242) | (392,699) | (394,849) | ||
Other undisclosed operating loss | (15,236) | (15,681) | (15,624) | (15,670) | ||||
Operating income: | 120,452 | 88,462 | 14,219 | 25,661 | 58,870 | 59,347 | ||
Nonoperating income (Investment Income, Nonoperating) | 19,785 | 19,365 | 18,044 | 15,740 | 12,612 | 11,943 | ||
Interest and debt expense | (3,574) | (3,547) | (6,098) | (3,779) | (3,755) | (3,703) | ||
Income from continuing operations before equity method investments, income taxes: | 136,663 | 104,280 | 26,165 | 37,622 | 67,727 | 67,587 | ||
Other undisclosed income (loss) from continuing operations before income taxes | (4,527) | 1,267 | (6,838) | 4,047 | 3,083 | (10,830) | ||
Income from continuing operations before income taxes: | 132,136 | 105,547 | 19,327 | 41,669 | 70,810 | 56,757 | ||
Income tax expense (benefit) | (24,962) | (16,885) | 1,048 | (1,291) | (14,770) | (5,905) | ||
Net income available to common stockholders, basic: | 107,174 | 88,662 | 20,375 | 40,378 | 56,040 | 50,852 | ||
Interest on convertible debt | 2,769 | 2,769 | 937 | 937 | ||||
Other undisclosed net loss available to common stockholders, diluted | (2,810) | |||||||
Net income available to common stockholders, diluted: | 109,943 | 91,431 | 17,565 | 40,378 | 56,977 | 51,789 |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 107,174 | 88,662 | 20,375 | 40,378 | 56,040 | 50,852 | ||
Comprehensive income: | 107,174 | 88,662 | 20,375 | 40,378 | 56,040 | 50,852 | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 27,845 | 27,742 | (35,045) | 24,874 | (7,895) | (6,855) | ||
Comprehensive income (loss), net of tax, attributable to parent: | 135,019 | 116,404 | (14,670) | 65,252 | 48,145 | 43,997 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.